(Date:12/2/2009)...STAD, The Netherlands, December 2 ...ology company focusing on protein mimicking,techno...ay announced that it,has appointed Wim E.M. Mol, P.... Mol will be responsible for all of Pepscans corp...ategic direction of the company. He brings to,Peps...
(Date:12/2/2009)...NJING, China, Dec. 2 /PRNewswire-Asia/ -- Simcere ...(NYSE: SCR ), a leading pharmaceutical company,s... marketing of branded,generic and proprietary phar...its drugs have been included in China,s National D...by China,s Ministry of Human Resources and Social,...
(Date:12/1/2009)... Dr. Kerry Solomon announced that he has joine... redesigned website at www.DrKerrySolomon.com , w...r. Solomon is a proven LASIK, lens implant, and ca...recognized for his substantial contributions to im... of Trusted LASIK Surgeons, which screens LASIK su...
(Date:12/1/2009)... Mass., Dec. 1 Harvest Technologie...sults from the company sponsored 60-patient clinic...er in Chennai, India using the company,s BMAC Syst...ical Limb Ischemia (CLI). Sri Ramachandra Medical ...ed institution based in Chennai, India and one of ...
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 2Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 3Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 4Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 5Charleston LASIK and Cataract Expert Dr. Kerry Solomon Opens New Practice and Launches DrKerrySolomon.com 6Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3.... 10 In a major victory for its client,Applera Co...ologies, Weil,Gotshal & Manges LLP won a summary j...fe sciences patents. In the action, Enzo Biochem, ...agents and instruments infringed,the patents in qu...le Janet Bond Arterton of the,United States Distri...
...trate that NKTR-118 Shows Promise for the Treatmen...ction, SAN CARLOS, Calif., Sept. 10 Nektar,Thera...t the American College,of Clinical Pharmacology co... 1 trial of NKTR-118 (oral PEG-naloxol). NKTR-118 ...for opioid bowel dysfunction (OBD),including opioi...
...r in Sept. 9 Issue of the Journal Nature Medicine,...th,devastating effects in people with normal chole...s who smoke, or have multiple risk factors. A new,... suffers a heart attack,and yet another doesn,t. ...Institute have,discovered a mechanism that contrib...
Other Biology Technology:Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 2Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 3Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 4Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting 5Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 2Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 3... between the body, mind and spirit has been the su...20 years. The notion that psychosocial and societa... and preventing disease became crystallized as a r...ns. In the 1970s, Cousins, then a writer and magaz...gnosed with an autoimmune disease. He theorized th...
...2009 / b3c newswire / - Addressing signi...e human diagnostics market, InVitria has announced...inant albumin products. InVitria’s Recombina...ee) perform better in diagnostics applications tha...ed human serum albumin (pHSA). , , The a...
...sease (AD) is a tragic disease that robs an indivi...ight people over the age of 65 now suffer from the...ed with the disease. Contrary to popular belief, A...ial Alzheimer,s disease (FAD), an offshoot of the ...udy , Alzheimer,s is a complex disease, and so to...
Other Biology News:Laughter remains good medicine 2Laughter remains good medicine 3InVitria Announces Launch of Recombinant Albumin for Diagnostics 2Computational model examines the pathways of Alzheimer's that strikes at the young 2Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D Systems
Rabbit Anti-ABIN-2 Polyclonal Antibody, Unconjugated from BioVision
Goat Anti-CLIM-2 (T-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Rabbit Anti-MD-2 (IN) Polyclonal Antibody, Unconjugated from AnaSpec
Biology Products: